CVE-2013-5210
Cross-site scripting (XSS) vulnerability in the GUI login page in ADTRAN AOS before R10.8.1 on...
Cross-site scripting (XSS) vulnerability in the GUI login page in ADTRAN AOS before R10.8.1 on the NetVanta 7100 allows remote attackers to inject arbitrary web script or HTML via unspecified vectors.
Exploit likelihood
What each source reports
NVD Score used
Cross-site scripting (XSS) vulnerability in the GUI login page in ADTRAN AOS before R10.8.1 on the NetVanta 7100 allows remote attackers to inject arbitrary web script or HTML via unspecified vectors.
- Record
CVE-2013-5210- CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List No score
Cross-site scripting (XSS) vulnerability in the GUI login page in ADTRAN AOS before R10.8.1 on the NetVanta 7100 allows remote attackers to inject arbitrary web script or HTML via unspecified vectors.
- Record
CVE-2013-5210- Updated
- 2026-11-02
EUVDEUVD-2013-5050 No score
Cross-site scripting (XSS) vulnerability in the GUI login page in ADTRAN AOS before R10.8.1 on the NetVanta 7100 allows remote attackers to inject arbitrary web script or HTML via unspecified vectors.
- Record
EUVD-2013-5050- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-vj9p-w6vw-49xq No score
Cross-site scripting (XSS) vulnerability in the GUI login page in ADTRAN AOS before R10.8.1 on...
Cross-site scripting (XSS) vulnerability in the GUI login page in ADTRAN AOS before R10.8.1 on the NetVanta 7100 allows remote attackers to inject arbitrary web script or HTML via unspecified vectors.
- Record
GHSA-vj9p-w6vw-49xq- Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2013-5210 is a medium vulnerability (CVSS 4.3) in Adtran Aos, published December 30, 2013. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.40%, the 72nd percentile. No source names a fixed version.